📊 Industry Moves
Oura Ring + LillyDirect partnership is genuinely smart: GLP-1 users need sleep and readiness data to optimize their therapy, and bundling free sizing kits removes the conversion barrier. This could actually drive adoption faster than Oura’s seen before.
Marty’s Take:
This signals that pharma is starting to treat wearables as therapeutic accessories, not lifestyle gadgets. Novo Nordisk is watching — a Wegovy partnership with Fitbit or Garmin is the obvious next move. The best fitness trackers in 18 months won’t just compete on steps and sleep; they’ll compete on clinical partnerships and prescription tie-ins.
Shop mentioned gear: Oura Ring
Source: MobiHealthNews





